Medical Image Enhancement Leader to Showcase World-Leading Product Upgrades, Investments in Deep Learning
STOCKHOLM – Feb. 22, 2017 – ContextVision will demonstrate its wide range of leading imaging enhancement software solutions at this year’s European Congress of Radiology (ECR) from March 2-5 at the Austria Center Vienna.
In addition to numerous product enhancements, ContextVision will also showcase its latest research in artificial intelligence. The company has been exploring the use of deep learning to optimize image quality, automate ultrasound and organ-specific segmentation with ultrasound. This has led to the debut of the company’s new branding, which highlights its new position within artificial intelligence technology.
“The progression of machine learning in medical imaging is proving itself to be efficient, customizable and cost effective,” commented Fredrik Palm, Vice President, ContextVision. “We believe it’s important to continue to adapt to this technological shift to provide the highest quality of care to patients.”
The following product updates will be available for demonstration:
- US PLUSView™ 2.0 on iOS – the world’s leading 2D image enhancement technology has been extended for implementation on the iOS platform, addressing the growing market for patient care and making ultrasound examinations accessible and affordable to more users outside traditional clinics.
- GOPView XR2Plus with extended OEM Tuning Tool – ContextVision’s gold standard image enhancement solution for digital radiography now offers x-ray system manufacturers the utmost tuning flexibility in parameter optimization to satisfy various preferences. The tuning tool allows for quick fine tuning, enabling a fast and precise workflow by making images easier to read.
“ContextVision continues to broaden our product portfolio to give customers high quality products. We are dedicated to ensuring the best image quality for multiple modalities,” Palm said. “We know that image quality continues to be of outmost importance for radiologists and we continuing to innovate in order to enhance the clinical value of medical imaging even further.”
For more information and demonstrations on these advancements in medical imaging, visit ContextVision at booth #7 in Hall X1 at ECR. To learn more about ContextVision’s collection of image enhancement software, visit www.contextvision.com/modalities.
ContextVision is a medical technology company specializing in image analysis and artificial intelligence. Its cutting-edge technology helps doctors accurately interpret medical images, a crucial foundation for better diagnosis and treatment. An industry pioneer for more than 30 years, ContextVision is taking a leading position within deep learning, the latest artificial intelligence technology, and is investing significantly in the field to expand the company’s product portfolio. The present product portfolio includes state-of-the-art image enhancement software for 2D/3D/4D ultrasound, MRI, X-ray and mammography which is used by leading equipment manufacturers worldwide. ContextVision is based in Sweden and listed on the Oslo Stock Exchange under the ticker COV. For more information, please visit www.contextvision.com.
Phone: +46 76 870 25 43